Cite

HARVARD Citation

    Bogdanffy, M. et al. (2014). Nonclinical Safety of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin. International journal of toxicology. pp. 436-449. [Online]. 
  
Back to record